T0	Participants 73 108	advanced pancreatic cancer patients
T1	Participants 298 345	patients with advanced pancreatic cancer (APC).
T2	Participants 348 422	cohort of 39 patients with APC, without thrombosis, receiving chemotherapy
T3	Participants 1523 1543	APC patients treated